Tg Therapeutics (TGTX) Operating Income Growth (1y) (2012 - 2026)
Powered by 
Analysis
Tg Therapeutics (TGTX) Operating Income Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 145.20% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 10.14% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 269.85% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1,528.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -36.55% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 99.51% |
| 10 | Tg Therapeutics | 7.97 Bn | 7.29 Bn | 199.14 Mn | -37.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.80% |
| Mar 31, 2026 | 303.56% |
| Dec 31, 2025 | 68.60% |
| Sep 30, 2025 | 136.17% |
| Jun 30, 2025 | 295.22% |
| Mar 31, 2025 | 193.01% |
| Dec 31, 2024 | 339.88% |
| Sep 30, 2024 | -89.17% |
| Jun 30, 2024 | 119.73% |
| Mar 31, 2024 | 74.94% |
| Dec 31, 2023 | 83.90% |
| Sep 30, 2023 | 428.30% |
| Jun 30, 2023 | -14.72% |
| Mar 31, 2023 | 44.68% |
| Dec 31, 2022 | 16.58% |
| Sep 30, 2022 | 58.93% |
| Jun 30, 2022 | 49.75% |
| Mar 31, 2022 | 25.03% |
| Dec 31, 2021 | -7.10% |
| Sep 30, 2021 | 0.69% |